Advertisement
You should not stop taking Jakafi (ruxolitinib) without first talking to your doctor. This drug is a long-term treatment for myelofibrosis, a condition in which bone marrow is replaced by scar tissue and blood cell production declines. If it works for you, it will relieve symptoms such as muscle and bone pain, fatigue and night sweats, but if you stop taking it, these symptoms will come back. If symptoms of myelofibrosis don't improve after six months of taking Jakafi, your doctor may take you off the drug.
Continue Learning about Pharmacology
Important: This content reflects information from various individuals and organizations and may offer alternative or opposing points of view. It should not be used for medical advice, diagnosis or treatment. As always, you should consult with your healthcare provider about your specific health needs.